secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001493152-23-003953
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix effects 1-for-20 reverse stock split, reducing outstanding shares to ~1.64M
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-20 effective 4:05 p.m. ET on Feb 8, 2023; adjusted trading starts Feb 9.
- Outstanding shares reduced from 32,894,359 to approximately 1,644,718, with fractional shares rounded up.
- Authorized shares unchanged at 40M; par value remains $0.001 per share.
- Proportional adjustments to equity awards, warrants, and convertible securities exercise prices and shares.
- Stock symbol remains NAOV; new CUSIP 63008J603.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223003953/0001493152-23-003953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223003953/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-003953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer